Monitor for any notice of appeal by the plaintiff within 30 days. If no appeal is filed, this case is effectively over for Abbott. The ruling removes a class-action overhang on ABT stock.
Price Chart
Executive Summary
The court denied with prejudice the plaintiff's renewed motion for class certification in a putative class action alleging false and misleading labeling on Abbott's Ensure nutrition drinks. The court also granted Abbott's motion in limine to exclude the plaintiff's expert damages model as unreliable. This ruling eliminates the risk of a class-wide damages award and materially reduces Abbott's litigation exposure in this case.
Court Ruling Details
Key Facts
- Court denied with prejudice plaintiff's renewed motion for class certification under Rule 23(b)(3).
- Court granted Abbott's motion in limine, excluding plaintiff's expert opinions on price premium damages as unreliable.
- Plaintiff's full-refund damages model was rejected because California law does not permit full refunds for food products with some value.
- Plaintiff's price premium model was excluded because it could not reliably measure damages attributable to the alleged misleading overall message.
- The ruling is final as to class certification and the expert exclusion; the case may proceed only as an individual action.
Financial Impact
No damages were awarded. The ruling eliminates the potential for a class-wide damages award, which could have been material given Ensure's significant market presence. The individual claim remaining is immaterial relative to Abbott's market cap.
Risk Factors
- Plaintiff may appeal the denial of class certification to the Ninth Circuit.
- Individual plaintiff's claims could still proceed to trial, though with minimal financial exposure.
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-d8a590eac3-ABT |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | Institutional Cluster | $102.51 | awaiting T+20 | — | $103.70 (+1.16%) |
Oct 21, 2026 4d ago | 8-K | $100.51 | awaiting T+20 | — | $103.70 (+3.17%) |
Oct 21, 2026 4d ago | 8-K | $100.51 | awaiting T+20 | — | $103.70 (−3.17%) |
Oct 21, 2026 4d ago | Press Release | $100.51 | awaiting T+20 | — | $103.70 (+3.17%) |
Oct 20, 2026 6d ago | Court Ruling | $100.51 | awaiting T+20 | — | $103.70 (+3.17%) |
Oct 16, 2026 10d ago | Court Ruling | $104.06 | awaiting T+20 | — | $103.70 (−0.35%) |
Oct 15, 2026 11d ago | Court Ruling | $104.89 | awaiting T+20 | — | $103.70 (−1.13%) |
Oct 7, 2026 18d ago | ANALYST-UPGRADE | $98.69 | awaiting T+20 | — | $103.70 (+5.08%) |
Oct 2, 2026 24d ago | ANALYST-UPGRADE | $97.50 | awaiting T+20 | — | $103.70 (+6.36%) |
Oct 2, 2026 24d ago | ANALYST-UPGRADE | $97.50 | awaiting T+20 | — | $103.70 (+6.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers